Australian and New Zealand Intensive Care Research Centre
51
12
17
22
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.0%
1 terminated/withdrawn out of 51 trials
95.7%
+9.2% vs industry average
27%
14 trials in Phase 3/4
9%
2 of 22 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (51)
SODium BICarbonate for Metabolic Acidosis in the ICU
Role: lead
Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis
Role: lead
Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults
Role: lead
The AminoECMO Pilot Trial
Role: lead
Fibrinogen Early In Severe Trauma StudY II
Role: lead
Improving Survivorship for Critically Ill Patients Aged 65 and Over
Role: lead
Indirect Calorimetry Guided Energy Provision in Critically Ill Patients With Obesity
Role: lead
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Role: lead
Red Blood Cell Transfusion in ECMO - A Feasibility Trial
Role: lead
RECOMMEND Platform Trial
Role: lead
Restricted or Liberal Fluid for Haemodynamic Resuscitation in Sepsis
Role: lead
The Cryopreserved vs. Liquid Platelets Trial
Role: lead
Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation
Role: lead
Nutrition Practice in Critically Ill Adults
Role: lead
Nutrition in Paediatric Critical Care
Role: lead
PRECISION-TBI - An Observational Study of Patients With Moderate to Severe Traumatic Brain Injury
Role: lead
Short Period Incidence Study of Severe Acute Respiratory Illness
Role: lead
Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial
Role: lead
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
Role: lead
Open Lung Ventilation in ARDS: The PHARLAP Trial
Role: lead